TC BioPharm (NASDAQ:TCBP) stock is up on Tuesday after the clinical-stage biopharmaceutical company announced an .
According to a press release from the company, it will host a presentation at the H.C. Wainwright 25th Annual Global Investment Conference. This event is set to take place on Sept. 11 and will last through Sept. 13.
TC BioPharm notes that CEO Bryan Kobel will lead the company’s presentation at the event. Management will also be taking part in one-on-one meetings both virtually and in-person during the event. The conference starts each day at 7:00 a.m. Eastern and lasts until 7:00 p.m. Eastern.
TCBP Stock Movement on Tuesday
TCBP stock has been on a wild ride this morning with volatility. That started with the company’s shares falling during early morning trading. However, it recovered from that before pre-market trading came to an end. That had the stock up slightly as of Tuesday morning.
As far as stock movement goes, only about 4,000 shares have changed hands as of this writing. That’s nowhere close to the company’s daily average trading volume of about 632,000 shares.
TC BioPharm is a clinical-stage biopharmaceutical company focused on developing immunotherapy products. Specifically, it makes use of its allogeneic gamma delta T cell platform for this work.
Investors on the lookout for even more of the biggest stock market stories today are in luck!
We’ve got all of the hottest stock market coverage that traders need to know about on Tuesday! That includes what’s moving shares of AgileThought (NASDAQ:AGIL) stock, Shineco (NASDAQ:SISI) stock and Tivic Health Systems (NASDAQ:TIVC) stock today. All of that news is available at the following links.
More Stock Market News for Tuesday
- Why Is AgileThought (AGIL) Stock Down 16% Today?
- Why Is Shineco (SISI) Stock Up 40% Today?
- Why Is Tivic Health Systems (TIVC) Stock Up 112% Today?
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.